Despite continued weakness in industrial markets, revenues for six major publicly traded analytical instrument and lab product businesses grew in the most recently ended quarter, benefitting in part from year-end budget releases and strength in Europe. Sales also climbed for each of the five businesses with fiscal years ending during the period 2013, despite weaker […]
For instrument and laboratory product companies, China has become the fastest growing market among major world economies. This is not surprising considering the country’s economic ascension and growing R&D spending. In 2013, analytical instrument sales (comprised of the product categories listed in the January 15 issue of IBO, including aftermarket products and service) to China […]
With only nine of the 16 companies in the IBO Laboratory Instrument Index reporting quarterly results before this issue’s publication, IBO estimates fourth quarter 2013 sales improved roughly 7%, or 6% excluding currency. The jump in growth was a result of strong results from Illumina and Waters, as well as the combined Agilent Technologies Life […]
With the capability of measuring physical, mechanical, electrical and other properties with nanometer resolution, atomic force microscopy (AFM) is a versatile technique. The advent of AFM-Raman spectroscopy in the late 1990s added to this versatility, enabling the addition of chemical information, including molecular orientation in polymers. Since that time, demand for the technique has grown […]
On February 6, the NIH announced the Accelerating Medicines Partnership (AMP), a collaboration among the agency, 10 pharmaceutical companies, seven nonprofit organizations and one trade group, the Pharmaceutical Research and Manufacturers of America (PhRMA). The program will be funded with more than $230 million over five years and will focus on three main areas: Alzheimer’s […]
Following newly reported financial information, IBO has updated quarterly sales and operating profit results for the Laboratory Sales Index that appeared in the November 15, 2013, issue. Third quarter 2013 Index sales grew 1.5%, 0.8% excluding currency, to $5,904 million. Operating profit climbed 2.7% to $1,206 million, and operating margin advanced 20 basis points to […]
To start the year, volatility returned to the equity markets as a consequence of mixed corporate earnings and slower jobs growth in the US, financial turmoil in emerging markets and weak manufacturing data for China. Adding to the anxieties, the US Federal Reserve reduced its monthly asset purchases by another $10 billion to $65 billion. […]
The annual Society for Laboratory Automation and Screening (SLAS) conference returned to San Diego, California, this year. Attendance at the conference bounced back after last year’s drop when it was held in Florida (see IBO 1/31/13), rising 53% to 5,819, nearly the same as the 2012 event (see IBO 2/15/12) (see table, page 3). SLAS […]
On January 17, more than three months into fiscal year 2014 (FY14), President Obama signed the Consolidated Appropriations Act of 2014. The omnibus bill will fund the federal government at a level of $1.1 trillion and will be effective through September 30. It restores support for many science programs to levels before the FY13 budget […]
In November 2013, Agilent Technologies launched the ProPulse 500 and 600 MHz NMR platforms for routine liquid applications. The ProPulse includes a completely new mid-field NMR console. This console introduction follows the 2011 release of the DD2 console (see IBO 5/15/11). “The ProPulse NMR System is our new mid-range NMR system, perfect for routine small […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
